Forodésine (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Forodésine" in French language version.

refsWebsite

Global rank French rank

4^th place

12^th place

2^nd place

3^rd place

low place

4,294^th place

low place

1,735^th place

168^th place

bloodjournal.org

(en) Balakrishnan K, Verma D, O'Brien S, Kilpatrick JM, Chen Y, Tyler BF, Bickel S, Bantia S, Keating MJ, Kantarjian H, Gandhi V, Ravandi F, « Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia », Blood, vol. 116, n^o 6,‎ 2010, p. 886-92. (PMID 20427701, PMCID PMC2924226, DOI 10.1182/blood-2010-02-272039, lire en ligne [html]) modifier.
(en) Alonso R, López-Guerra M, Upshaw R, Bantia S, Smal C, Bontemps F, Manz C, Mehrling T, Villamor N, Campo E, Montserrat E, Colomer D, « Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM », Blood, vol. 114, n^o 8,‎ 2009, p. 1563-75. (PMID 19541822, DOI 10.1182/blood-2009-02-207654, lire en ligne [html]) modifier.

(en) Balakrishnan K, Verma D, O'Brien S, Kilpatrick JM, Chen Y, Tyler BF, Bickel S, Bantia S, Keating MJ, Kantarjian H, Gandhi V, Ravandi F, « Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia », Blood, vol. 116, n^o 6,‎ 2010, p. 886-92. (PMID 20427701, PMCID PMC2924226, DOI 10.1182/blood-2010-02-272039, lire en ligne [html]) modifier.
(en) Alonso R, López-Guerra M, Upshaw R, Bantia S, Smal C, Bontemps F, Manz C, Mehrling T, Villamor N, Campo E, Montserrat E, Colomer D, « Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM », Blood, vol. 114, n^o 8,‎ 2009, p. 1563-75. (PMID 19541822, DOI 10.1182/blood-2009-02-207654, lire en ligne [html]) modifier.

(en) Balakrishnan K, Verma D, O'Brien S, Kilpatrick JM, Chen Y, Tyler BF, Bickel S, Bantia S, Keating MJ, Kantarjian H, Gandhi V, Ravandi F, « Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia », Blood, vol. 116, n^o 6,‎ 2010, p. 886-92. (PMID 20427701, PMCID PMC2924226, DOI 10.1182/blood-2010-02-272039, lire en ligne [html]) modifier.
(en) Alonso R, López-Guerra M, Upshaw R, Bantia S, Smal C, Bontemps F, Manz C, Mehrling T, Villamor N, Campo E, Montserrat E, Colomer D, « Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM », Blood, vol. 114, n^o 8,‎ 2009, p. 1563-75. (PMID 19541822, DOI 10.1182/blood-2009-02-207654, lire en ligne [html]) modifier.

Masse molaire calculée d’après « Atomic weights of the elements 2007 », sur www.chem.qmul.ac.uk.

(en) Balakrishnan K, Verma D, O'Brien S, Kilpatrick JM, Chen Y, Tyler BF, Bickel S, Bantia S, Keating MJ, Kantarjian H, Gandhi V, Ravandi F, « Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia », Blood, vol. 116, n^o 6,‎ 2010, p. 886-92. (PMID 20427701, PMCID PMC2924226, DOI 10.1182/blood-2010-02-272039, lire en ligne [html]) modifier.
(en) Alonso R, López-Guerra M, Upshaw R, Bantia S, Smal C, Bontemps F, Manz C, Mehrling T, Villamor N, Campo E, Montserrat E, Colomer D, « Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM », Blood, vol. 114, n^o 8,‎ 2009, p. 1563-75. (PMID 19541822, DOI 10.1182/blood-2009-02-207654, lire en ligne [html]) modifier.